About Avanos
Avanos is a company based in Alpharetta (United States) founded in 2014. The company has 2,230 employees. Avanos has completed 4 acquisitions, including Avanos Medical, Diros Technology and Endoclear. Avanos operates in a competitive market with competitors including Soovu, SpinaFX Medical, AVACEN Medical, Dhama Innovations and Avancen, among others.
- Headquarter Alpharetta, United States
- Employees 2,230
- Stage Public
- SectorsHealthcare
- Phone•••• ••••
- Website avanos.com
- Social LinkedIn X Facebook
- Acquired by Myairlife (Oct 2023)
- Legal Name Avanos Medical, Inc.
- Annual Revenue₹36.40 Cr
FY 2025 · -13% YoY
- Net Profit₹1.21 Cr
FY 2025 · 3% margin
- EBITDA₹2.17 Cr
FY 2025 · 6% margin
- Latest Funding Round$250M (USD), Debt – Conventional
Jan 2019
- InvestorsCiti
& 1 more
- Employee Count2,230
- Investments & AcquisitionsAvanos Medical
& 3 more
Associated legal entities of Avanos
Avanos operates through Avanos Medical India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Avanos Medical India Private Limited CIN U74900MH2014PTC339829 | Active | 28 Aug 2014 | Mumbai, Maharashtra | ₹36.4 Cr | 26 | 2 | View details |
Funding Insights of Avanos
- Total Rounds 1
- Last Round Debt – Conventional — $250M
- First Round $250M
(Jan 2019)
- Investors Count 1
All 1 funding rounds of Avanos with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2019 | $250M | Debt – Conventional | – | – |
2 investors in total: 2 institutional.
Investors in Avanos
Avanos has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Citi and AirLife.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Diversified financial services are offered through commercial banking operations. | 1812 | citigroup.com | New York, United States | |
AirLife is recognized as a leading manufacturer and distributor of consumable medical devices for anesthesia and respiratory care in North America. | – | myairlife.com | Grand Rapids, USA |
Investor details for Avanos
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Avanos Medical India Private Limited (Avanos)
Avanos Medical India Private Limited is the primary company behind Avanos. The board of Avanos Medical India Private Limited currently have 2 directors; the longest-serving is Gaurav Gajendra Mandawat, appointed in 2023. 13 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Gaurav Gajendra Mandawat DIN 10089576 | Director | 27 Mar 2023 | 3 yrs 6 mo | Avanos Medical India Private Limited |
| Kerr William Holbrook DIN 11211904 | Director | 24 Jul 2025 | 1 yr 2 mo | Avanos Medical India Private Limited |
People of Avanos
264 people are tracked at Avanos (73 in leadership, 191 in team); the tracked headcount is 2,230.
| Name | Role | Group |
|---|---|---|
Joe Woody | CEO | Leadership |
Dennis Johnson | Director Global RFA & Market Acess | Leadership |
Mona Kassam | Associate Director HRBP US & Canada | Leadership |
Camille Chang Gilmore | Senior Vice President & Chief Human Resources Officer | Leadership |
Amy Winegarden | Director, Regulatory Affairs | Leadership |
Jose Gamez | Associate Director | Leadership |
Marco Monroy | Plant General Manager | Leadership |
Suzanne Kelly | Regional Vice President, Europe North, West And Central | Leadership |
Kristie Palermo Carubba | Director Of National And Corporate Accounts | Leadership |
Julie M. | Sr Human Resources Business Partner | Leadership |
Nancy Vanderoost | Senior Director, International Human Resources | Leadership |
Kelly Hansen | Sr. Director, Sales And Marketing - Game Ready | Leadership |
Roy Wang | Senior Director | Leadership |
Chip Hartigan | National Sales Director | Leadership |
Veronica Noess | Associate Director Of Distribution And Global Transportation | Leadership |
Shawnna van Pelt | Vice President, Global Human Resources & Labor Relations | Leadership |
Stacie Schulze | Associate Director, Toxicology & Biocompatibility | Leadership |
Robert Beasley | National Sales & Marketing Director | Leadership |
Sonia Rodriguez | Sr Director Global Post Market Surveillance And Compliance | Leadership |
Marco Cangialeoni | Customer Service Distributor Accounts Partner | Leadership |
244 more people are available in the full profile.
Complete people profiles for Avanos
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Avanos
Avanos is a publicly listed company on the NYSE with ticker symbol AVNS in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date24 Oct 2014
- Listed onNYSE: AVNS
- Listed entityAvanos Medical, Inc.
- Exchange sectorHealth technology
- ISINUS05350V1061
- Share price$24.80 (+0.12% on the day) · 2026-05-11
- Market capitalisation$1.16B
- EPS (diluted, trailing year)$-1.61
- Volume (last session)965,890
- Analyst consensusNeutral
Financials of Avanos
Figures of Avanos Medical India Private Limited, the primary company behind Avanos, for FY 2025. Revenue was ₹36.40 Cr (-13% year on year). Net profit was ₹1.21 Cr (3% margin). EBITDA was ₹2.17 Cr (6% margin). Revenue has grown at a compounded annual rate of +9% over three years and +8% over five years.
- ₹36.40 CrRevenue · FY 2025 · -13% YoY
- ₹1.21 CrNet profit · 3% margin
- ₹2.17 CrEBITDA · 6% margin
- ₹8.4 LakhPaid-up capital
- 26Employees (provident fund records)
- +9%Revenue CAGR, 3 years
- +8%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2024 | $687.8M | -$392.1M | $85.5M |
| 2023 | $673.3M | -$61.8M | $108.5M |
| 2022 | $684.1M | $50.5M | $83.0M |
| 2021 | $744.6M | $6.3M | $125.1M |
| 2020 | $714.8M | -$27.2M | $113.8M |
Balance sheet, profit and loss, cash flow and ratios of Avanos Medical India Private Limited are on its company page.
Detailed financial statements for Avanos
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Avanos
Avanos has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Avanos Medical, Diros Technology and Endoclear.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Medical device outsourcing services are provided to clients. | dirostech.com | Markham, Canada | 1983 | Jun 2023 | •••• | |
Generic Class III medical devices in orthopedics are developed. | orthogenrx.com | Doylestown, United States | 2012 | Dec 2021 | $160M | |
Devices to clear away film and blockages in breathing tubes | endoclearllc.com | San Ramon, United States | 2009 | Nov 2019 | •••• | |
A portfolio of neonatal care products is developed and sold. | neomedinc.com | Woodstock, United States | 2007 | Aug 2019 | $28M |
Complete acquisition details for Avanos
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Avanos
8 dated milestones of Avanos across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Avanos is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $250.0M.
- Acquisition Acquires Avanos Medical.
- Acquisition Acquires Endoclear.
- Acquisition Acquires OrthogenRx.
- Acquisition Acquires Diros Technology.
- Exit Acquired by Myairlife.
Competitors of Avanos
Avanos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Soovu, SpinaFX Medical, AVACEN Medical, Dhama Innovations and Avancen, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| soovu.com | 2016 | Seattle, United States | $8.48M | – | Drug-free wearable pulsed heat therapy for pain management is developed. | |
| spinafx.com | 2021 | Vaughan, Canada | $9.1M | – | Minimally invasive oxygen-ozone therapy for herniated discs is provided. | |
| avacen.com | 2009 | San Diego, United States | – | 8 | Provides noninvasive drug-free heat therapy for muscle and joint pain relief. | |
| dhamainnovations.com | 2008 | Hyderabad, India | $1.11M | 4 | Temperature-controlled wearables for pain relief and leisure are designed. | |
| avancen.com | 2007 | Mount Pleasant, United States | $2.21M | – | Medication management devices are supplied to hospitals and patients. | |
| tidewave.no | 2017 | Stavanger, Norway | – | 26 | Smart devices for pain management in patients are provided. | |
| biophotas.com | 2007 | Tustin, United States | $2.38M | 32 | A device using photo-modulation technologies to treat skin, muscle and joint conditions. | |
| gap-flex.com | 2014 | San Antonio, United States | $930,748 | – | Therapeutic systems for knee pain management are provided. |
Detailed competitors of Avanos
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Avanos
The website of Avanos (avanos.com) receives about 44K visits a month.
- Monthly visits44K
▼ 12.1% vs previous month
Websites whose visitors overlap most with Avanos. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bioclinicalservices.com.au | 100% | 42.4K | #740,799 | View details | |
| appliedmedical.net | 100% | – | #1,386,219 | View details | |
medicalsuppliesfast.com | medicalsuppliesfast.com | 85% | – | #2,454,365 | – |
| carewell.com | 83% | 611K | #76,793 | View details | |
| byramhealthcare.com | 81% | 304.6K | #167,363 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 19 similar websites and full traffic analytics for Avanos
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Avanos
Complete news archive for Avanos
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Avanos
10 companies that operate in the same segment as Avanos (Pain Management), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Developer of therapeutics for pain relief and inflammatory diseases | 2004 | New York, New York, United States | USD 51 M | USD 4.33 M | 79 | |
GPCR ligand-based therapeutics for cardiovascular diseases and pain are developed. | 2007 | Philadelphia, Pennsylvania, United States | USD 203 M | USD 3.13 M | 35 | |
Therapeutics for migraine treatment are developed using nasal delivery. | 2016 | San Francisco, California, United States | USD 74.13 M | – | 24 | |
Pain treatment products are developed through reformulation technologies. | 2007 | Herzliya, Central District, Israel | USD 12 M | USD 17 K | 6 | |
Drug delivery systems for CNS disorders and pain are developed. | 2006 | Emeryville, California, United States | USD 149.06 M | – | – | |
Developer of neuromodulation platform measuring biomarkers for chronic neurological condition treatment | 2010 | Bloomington, Indiana, United States | USD 530 M | USD 91.65 M | – | |
Therapies for pain and addiction treatment are developed. | 1977 | Saint-cloud, France | USD 248.09 M | USD 167.87 M | – | |
Novel drug products for chronic pain treatment are developed. | 2007 | Blue Bell, Pennsylvania, United States | USD 12.96 M | – | 17 | |
Abuse-deterrent extended-release therapeutics for chronic pain are developed. | 2002 | Canton, Ohio, United States | USD 103 M | USD 780.57 M | 357 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Avanos
Avanos was founded in 2014 and raised its 1st funding round 5 years after it was founded.
Avanos is headquartered in Alpharetta, United States. It is registered at Alpharetta, Georgia, United States.
Joe Woody is the current CEO of Avanos.
Avanos has 2,230 employees.
The primary company behind Avanos, Avanos Medical India Private Limited, reported revenue of ₹36.40 Cr for FY 2025, down 13% year on year.
Avanos was founded in 2014 in Alpharetta, United States, within the medical devices sector. Devices for pain management and enteral feeding are produced, including pain pumps, radiofrequency ablation systems, and feeding tubes with accessories. These products support specialties such as surgical pain, interventional pain, and neonatal care. Operations extend to hospitals, clinics, and home healthcare across acute and chronic needs, with nutritional support for enteral feeding provided.
Avanos's top competitors include SpinaFX Medical, Dhama Innovations and Soovu.
Yes, Avanos is publicly traded on NYSE under the ticker symbol AVNS.
Avanos has made 4 acquisitions, including Avanos Medical, Diros Technology, and Endoclear.
Avanos operates through Avanos Medical India Private Limited.
Yes. Avanos was acquired by Myairlife in October 2023.